PATENT CLAIM ANALYSIS

Application Number: 16217360
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["424", "001410"]

Abstract:
Provided herein are antibodies that specifically bind Tau and methods of using the same.

Claim (Index 22):
The monoclonal antibody or antigen-binding fragment according to  claim 1 , wherein the antibody or antigen-binding fragment binds to human Tau at an epitope comprising the amino acid sequence HVPGG (SEQ ID NO: 79).

Metadata:
- Claim Count in Document: 65.0
- Percentile: 98.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15559791', '16190676', '14356557', '15699902', '15226744']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7629972145488141
- 35 USC 102 Novelty (BERT): 0.5552439715676856
- Combined Prediction Score: 0.7422218902507013
- Mean Citation Score: 447.975692
- Max Citation Score: 454.3782
- Similarity Product: 328.91607362651825

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test